Regulation strengthening

o mobilize short-term support upon request in the pharmaceutical sector for all outputs, and to mobilize international, regional and national experts in access to health products (additional funding). This will contribute to strengthen local actors and institutions to improve access to quality healt

h products. The current consultation concerns the signing of a Framework Agreement with the aim to provide technical, managerial, institutional and/or transversal support. The type of support and the level of responsibility linked to it wil